skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The J-elongated conformation of β2-glycoprotein I predominates in solution: Implications for our understanding of antiphospholipid syndrome

Journal Article · · Journal of Biological Chemistry

β2-Glycoprotein I (β2GPI) is an abundant plasma protein displaying phospholipid-binding properties. Because it binds phospholipids, it is a target of antiphospholipid antibodies (aPLs) in antiphospholipid syndrome (APS), a life-threatening autoimmune thrombotic disease. Indeed, aPLs prefer membrane-bound β2GPI to that in solution. β2GPI exists in two almost equally populated redox states: oxidized, in which all the disulfide bonds are formed, and reduced, in which one or more disulfide bonds are broken. Furthermore, β2GPI can adopt multiple conformations (i.e. J-elongated, S-twisted, and O-circular). While strong evidence indicates that the J-form is the structure bound to aPLs, which conformation exists and predominates in solution remains controversial, and so is the conformational pathway leading to the bound state. Here, we report that human recombinant β2GPI purified under native conditions is oxidized. Moreover, under physiological pH and salt concentrations, this oxidized form adopts a J-elongated, flexible conformation, not circular or twisted, in which the N-terminal domain I (DI) and the C-terminal domain V (DV) are exposed to the solvent. Consistent with this model, binding kinetics and mutagenesis experiments revealed that in solution the J-form interacts with negatively charged liposomes and with MBB2, a monoclonal anti-DI antibody that recapitulates most of the features of pathogenic aPLs. We conclude that the preferential binding of aPLs to phospholipid-bound β2GPI arises from the ability of its preexisting J-form to accumulate on the membranes, thereby offering an ideal environment for aPL binding. We propose that targeting the J-form of β2GPI provides a strategy to block pathogenic aPLs in APS.

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
National Institutes of Health (NIH); CaRiPaRo Foundation; USDOE Office of Science (SC), Basic Energy Sciences (BES)
Grant/Contract Number:
AC02-06CH11357; 2018 BPiTA-52012; HL150146; HL049413; HL139554; HL147821
OSTI ID:
1772485
Alternate ID(s):
OSTI ID: 1774512
Journal Information:
Journal of Biological Chemistry, Vol. 295, Issue 31
Publisher:
American Society for Biochemistry and Molecular BiologyCopyright Statement
Country of Publication:
United States
Language:
English

References (71)

Simulation and Theory of Antibody Binding to Crowded Antigen-Covered Surfaces journal March 2016
PAM: A Framework for Integrated Analysis of Imaging, Single-Molecule, and Ensemble Fluorescence Data journal April 2018
Complete amino acid sequence of human plasma beta 2-glycoprotein I. journal June 1984
Impact of Antigen Density on the Binding Mechanism of IgG Antibodies journal June 2017
The Pathogenesis of the Antiphospholipid Syndrome journal March 2013
β2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin journal October 1990
IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2–glycoprotein I cause LAC, and their presence correlates strongly with thrombosis journal February 2005
Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies journal October 2007
β2-glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model journal March 2011
Dimerized Domain V of Beta2-Glycoprotein I Is Sufficient to Upregulate Procoagulant Activity in PMA-Treated U937 Monocytes and Require Intact Residues in Two Phospholipid-Binding Loops journal June 2017
Accurate FRET Measurements within Single Diffusing Biomolecules Using Alternating-Laser Excitation journal April 2005
Chemical synthesis and characterization of wild-type and biotinylated N-terminal domain 1-64 of β2-glycoprotein I journal March 2010
A non–complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome journal May 2014
Crystal structure of human β2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome journal November 1999
The effect of phospholipids on the formation of immune complexes between autoantibodies and β2-glycoprotein I or prothrombin journal August 2004
Discovery and characterization of 2 novel subpopulations of aPS/PT antibodies in patients at high risk of thrombosis journal June 2019
Adhesion mechanism of human beta 2-glycoprotein I to phospholipids based on its crystal structure journal October 1999
Toward dynamic structural biology: Two decades of single-molecule Förster resonance energy transfer journal January 2018
Allosteric activation of ADAMTS13 by von Willebrand factor journal December 2014
Interdomain Contact Regions and Angles Between Adjacent Short Consensus Repeat Domains journal December 2004
Anticardiolipin antibodies and β2-glycoprotein I journal April 1996
Beta 2 glycoprotein I is a substrate of thiol oxidoreductases journal September 2010
Pulsed Interleaved Excitation journal November 2005
Regulators of complement activity mediate inhibitory mechanisms through a common C3b‐binding mode journal March 2016
Structural Architecture of Prothrombin in Solution Revealed by Single Molecule Spectroscopy journal July 2016
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). journal June 1990
β2-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome journal August 2010
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor journal June 1990
Plasmin Can Reduce the Function of Human β2Glycoprotein I by Cleaving Domain V Into a Nicked Form journal June 1998
Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation journal March 2017
Single-Molecule FRET with Diffusion and Conformational Dynamics journal November 2007
Immune responses against domain I of β2-glycoprotein I are driven by conformational changes: Domain I of β2-glycoprotein I harbors a cryptic immunogenic epitope journal November 2011
β2-Glycoprotein I: evolution, structure and function: β2-Glycoprotein I journal July 2011
Anti- 2 glycoprotein I ( 2GPI) autoantibodies recognize an epitope on the first domain of  2GPI journal December 1998
Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite Antiphospholipid Syndrome journal May 2012
Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity. journal March 1993
Determination of Domain Structure of Proteins from X-Ray Solution Scattering journal June 2001
In Vivo Models of Thrombosis for the Antiphospholipid Syndrome journal October 1996
Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies journal March 2005
β2-Glycoprotein I: a novel component of innate immunity journal June 2011
Structure of Coagulation Factor II: Molecular Mechanism of Thrombin Generation and Development of Next-Generation Anticoagulants journal October 2018
Identification of the binding site for fondaparinux on Beta2-glycoprotein I journal October 2013
Antibodies to Domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS) journal December 2011
Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns journal December 2018
New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats journal November 2018
Pathogenesis of antiphospholipid syndrome: understanding the antibodies journal May 2011
Dimers of β2-Glycoprotein I Increase Platelet Deposition to Collagen via Interaction with Phospholipids and the Apolipoprotein E Receptor 2′ journal September 2003
Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activity: Anti-β2GPI antibodies with LAC activity journal April 2011
The X-ray Crystal Structure of Full-Length Human Plasminogen journal March 2012
Fluorescence-aided molecule sorting: Analysis of structure and interactions by alternating-laser excitation of single molecules journal June 2004
Molecular mapping of α-thrombin (αT)/β2-glycoprotein I (β2GpI) interaction reveals how β2GpI affects αT functions journal December 2016
Coot model-building tools for molecular graphics journal November 2004
Mechanism of the Interaction of β 2 -Glycoprotein I with Negatively Charged Phospholipid Membranes journal November 2001
Lysine residues control the conformational dynamics of beta 2-glycoprotein I journal January 2018
The Antiphospholipid Syndrome journal March 2002
A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies journal January 2012
Pathogenic anti-β2-glycoprotein I antibodies recognize domain I of β2-glycoprotein I only after a conformational change journal March 2006
Lupus Anticoagulant Activity Is Frequently Dependent on the Presence of β2-Glycoprotein I journal January 1992
[Anti-β2 Glycoprotein I—β2 Glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases journal February 1999
Shot-Noise Limited Single-Molecule FRET Histograms:  Comparison between Theory and Experiments journal November 2006
Functional and structural insight into properdin control of complement alternative pathway amplification journal March 2017
Mode of Interaction between β2GPI and Lipoprotein Receptors Suggests Mutually Exclusive Binding of β2GPI to the Receptors and Anionic Phospholipids journal March 2010
Structure of prothrombin in the closed form reveals new details on the mechanism of activation journal February 2018
Use of Single Point Mutations in Domain I of β 2 -Glycoprotein I to Determine Fine Antigenic Specificity of Antiphospholipid Autoantibodies journal December 2002
Solution Structure of Human and Bovine β2-Glycoprotein I Revealed by Small-angle X-ray Scattering journal August 2002
A practical guide to small angle X-ray scattering (SAXS) of flexible and intrinsically disordered proteins journal August 2015
Induction of anti-β2-glycoprotein I autoantibodies in mice by protein H of Streptococcus pyogenes: Induction of anti-β2-GPI autoantibodies journal December 2011
Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β 2 ‐glycoprotein I journal August 2011
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
�ber ein bisher unbekanntes niedermolekulares ?2-Glubulin des Humanserums journal January 1961
Thrombus formation induced by antibodies to β2-glycoprotein I is complement dependent and requires a priming factor journal October 2005